Key Insights

Highlights

Success Rate

95% trial completion (above average)

Published Results

57 trials with published results (11%)

Research Maturity

313 completed trials (59% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

2.8%

15 terminated out of 532 trials

Success Rate

95.4%

+8.8% vs benchmark

Late-Stage Pipeline

31%

163 trials in Phase 3/4

Results Transparency

18%

57 of 313 completed with results

Key Signals

57 with results95% success15 terminated

Data Visualizations

Phase Distribution

443Total
Not Applicable (156)
Early P 1 (2)
P 1 (71)
P 2 (51)
P 3 (88)
P 4 (75)

Trial Status

Completed313
Unknown103
Recruiting42
Not Yet Recruiting21
Withdrawn19
Terminated15

Trial Success Rate

95.4%

Benchmark: 86.6%

Based on 313 completed trials

Clinical Trials (532)

Showing 20 of 20 trials
NCT04601233Phase 4Withdrawn

Testosterone Treatment for Erectile Dysfunction and Multiple Sclerosis

NCT07856199Not ApplicableRecruiting

Pudendal Atherosclerosis by IVUS-NIRS in Men With Coronary Artery Disease

NCT07819084Not ApplicableNot Yet RecruitingPrimary

Shockwave Therapy on Treating Erectile Dysfunction Following Nerve-sparing Radical Prostatectomy.

NCT06167733Not ApplicableActive Not RecruitingPrimary

Safety and Efficacy of the VERTICA® RF Device for the Treatment of ED

NCT04349059Not ApplicableCompletedPrimary

The Impact of Dietary Pattern on Erectile Function

NCT07311330Phase 2Recruiting

Phase IIa Clinical Trial of YN001 in Patients With Atherosclerotic Cardiovascular and Cerebrovascular Diseases and Erectile Dysfunction

NCT07834164Phase 2CompletedPrimary

A Randomized Double-Blind Clinical Study of Intracavernosal OnabotulinumtoxinA Injection in Patients With Erectile Dysfunction Refractory to Phosphodiesterase-5 Inhibitors

NCT07831551Not ApplicableNot Yet Recruiting

EECP for Erectile Dysfunction in Elderly Hypertensive Patients

NCT07820748Not ApplicableRecruitingPrimary

Linear Piezoelectric Low Intensity Shockwave Treatment (LI-SWT) for the Treatment of Erectile Dysfunction in PDE5i Non Responder

NCT04200937Enrolling By InvitationPrimary

IT Matters: The Erectile Restoration Registry

NCT07685249Not ApplicableNot Yet Recruiting

Rehabilitation and Sex Therapy to Optimize Recovery After Prostate Cancer Treatment

NCT07053826Not ApplicableRecruitingPrimary

Penile Lengthening Pre-Penile Prosthesis Implantation

NCT07574268Phase 4CompletedPrimary

Efficacy of Transcutaneous Electrical Neural Stimulation and Tadalafil in Men With Erectile Dysfunction: A Randomized, Double-Blind, Bi-centric, Placebo- and Sham-Controlled Trial

NCT07479901CompletedPrimary

Atherogenic Index of Plasma and Tadalafil Response in Erectile Dysfunction

NCT07753720Phase 4RecruitingPrimary

Daily Tadalafil as Adjunctive Therapy Versus Monotherapy for PDE5 Inhibitor-Resistant Erectile Dysfunction

NCT07783958RecruitingPrimary

Male Sexual Function and Sexual Quality of Life in Polygamous Versus Monogamous Marriages

NCT07783347Not ApplicableNot Yet RecruitingPrimary

Platelet-Rich Plasma Alone Versus PRP Plus Low-Intensity Shock Wave Therapy for Erectile Dysfunction

NCT05868668Not ApplicableRecruiting

Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain

NCT07537855Phase 2Not Yet RecruitingPrimary

Efficacy of Intracavernosal Xeomin With Tadalafil for Mild-Moderate Erectile Dysfunction

NCT07758842Not ApplicableRecruitingPrimary

Lifestyle Modification for Erectile Dysfunction in Men With Metabolic Syndrome

Scroll to load more

Research Network

Activity Timeline